Jianwei Liao
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Gut Microbiota Modulates the Protective Role of Ginsenoside Compound K Against Sodium Valproate-Induced Hepatotoxicity in Rat.
Journal: Frontiers in microbiology
Published: May 13, 2022
The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial.
Journal: Frontiers in pharmacology
Published: August 08, 2021
CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population.
Journal: Frontiers in pharmacology
Published: June 25, 2021
Pharmacokinetic Study of Oral 14C-Radiolabeled Hyzetimibe, A New Cholesterol Absorption Inhibitor.
Journal: Frontiers in pharmacology
Published: February 08, 2021
Ginsenoside compound K alleviates sodium valproate-induced hepatotoxicity in rats via antioxidant effect, regulation of peroxisome pathway and iron homeostasis.
Journal: Toxicology and applied pharmacology
Published: July 19, 2019
Impact of NR1I2, adenosine triphosphate-binding cassette transporters genetic polymorphisms on the pharmacokinetics of ginsenoside compound K in healthy Chinese volunteers.
Journal: Journal of ginseng research
Published: February 07, 2018
Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers.
Journal: Frontiers in pharmacology
Published: October 26, 2017
Food and Sex-Related Impacts on the Pharmacokinetics of a Single-Dose of Ginsenoside Compound K in Healthy Subjects.
Journal: Frontiers in pharmacology
Published: June 04, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026